Drawing for BELIXOS

USPTO serial 79070762

BELIXOS

Reviewed by CopyMark Law Group

Reg. 3771836Status 709
Filing date
Status date
Registration date
Apr 6, 2010
Examiner
CORWIN, KEVIN SCOTT
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BELIXOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JENNIFER FRASER

JENNIFER FRASER Dykema Gossett PLLC1301 K Street, NWSuite 1100 WestWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposes, namely, medicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; [ * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements * ] * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements *SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 15, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 19, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 18, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Jun 13, 2019RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 6, 2019REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 12, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 12, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 8, 2016INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 8, 2016INPCINVALIDATION PROCESSED—
Sep 8, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 8, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 8, 201671AGREGISTERED-SEC.71 ACCEPTED—
Jan 8, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 28, 2015ES71TEAS SECTION 71 RECEIVED—
Aug 28, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 27, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 15, 2015INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 24, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 24, 2014COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jul 24, 2014PLGLASSIGNED TO PARALEGAL—
Jul 23, 2014LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Jul 4, 2014LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Apr 30, 2014INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jun 4, 2013INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 7, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 4, 2012COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 4, 2012PLGLASSIGNED TO PARALEGAL—
Oct 4, 2012LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Sep 28, 2012LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 28, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 28, 2010FIMPFINAL DISPOSITION PROCESSED—
Jul 28, 2010LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jul 7, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 6, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 19, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 11, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 11, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2009CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 11, 2009ALIEASSIGNED TO LIE—
Nov 24, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 24, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 6, 2009LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 29, 2009RFNTREFUSAL PROCESSED BY IB—
Sep 23, 2009CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Sep 18, 2009CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 4, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 4, 2009RFRRREFUSAL PROCESSED BY MPU—
Sep 4, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 3, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2009DOCKASSIGNED TO EXAMINER—
Aug 11, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 7, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance